Don’t miss the opportunity to discover the boundless potential of our patented MTC-Y technology. Explore our recent achievements in notable projects, including transdermal semaglutide and insulin.
Save the date!
Whether you’re eager to delve into our innovative technology or explore opportunities for collaboration, our key team members, CEO Jan Hendriks and CTO Paweł Biernat will be there, eager to engage with you and facilitate discussions.
See you in Munich!